PI3 kinase inhibitor (Merck Serono)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NamePI3 kinase inhibitor (Merck Serono)

Drug Alias NamePI3K-gamma inhibitor (Serono)phosphoinositide 3-kinase gamma inhibitor (Merck Serono)phosphoinositide 3-kinase gamma inhibitor (Serono)PI3K-gamma inhibitor (Merck Serono)PI3 kinase inhibitor (Serono) +[8]

ClassificationSmall molecules

Mechanisms of ActionPI3-kinase class I inhibitorsChemotaxis inhibitors

TargetsPI3-kinase class I

Therapy Area/IndicationsInflammationLupus Erythematosus, SystemicArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMerck Serono Sa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMerck Serono Sa

Active IndicationsN/A

Inactive IndicationsInflammationLupus Erythematosus, SystemicArthritis, Rheumatoid

Other Information

ATC CodeN/A